JPRN-UMIN000030527招募中未知
The efficacy of droxidopa fot the patients with MAPT mutation and PSP evaluated by tau imaging. - The efficacy of droxidopa fot the patients with MAPT mutation and PSP evaluated by tau imaging.
Juntendo University School of Medicine0 个研究点目标入组 15 人开始时间: 2018年1月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
We examined tau-imaging for 14 patients with sporadic PSP and one patient with MAPT N279K. The results partially showed the spreading and increased accumulation of tau protein. Our sequential examinations confirmed the increased tau protein in vivo.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12months-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclude the patients not defined the above criteria.
研究者
相似试验
终止
3 期
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapySymptomatic Neurogenic Orthostatic HypotensionMultiple Systems AtrophyPure Autonomic FailureDopamine Beta Hydroxylase DeficiencyParkinson's DiseaseNCT01927055Chelsea Therapeutics61
已完成
3 期
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaSymptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic FailureDopamine Beta Hydroxylase DeficiencyNCT00782340Chelsea Therapeutics263
已完成
3 期
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic FailureDopamine Beta Hydroxylase DeficiencyNCT00633880Chelsea Therapeutics181
Enrolling By Invitation
2 期
Droxidopa / Pyridostigmine in Orthostatic HypotensionOrthostatic HypotensionNCT01370512Mayo Clinic30
已完成
不适用
Droxidopa in Treating Patients With Neurogenic HypotensionShy-Drager SyndromeOrthostatic HypotensionNCT00004478Icahn School of Medicine at Mount Sinai